Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B

🔗 Access full article via BMC Virology Journal

Concerns have been raised regarding changes in lipid profiles among patients with chronic hepatitis B (CHB) during tenofovir alafenamide fumarate (TAF) treatment. We aimed to evaluate the effect of TAF treatme…

Continue reading on BioMed Central